Papers in Oncolytic Virotherapy
Page 1 · newest first
- The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma TreatmentOncolytic Virotherapy · 2021
- Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and OclacitinibOncolytic Virotherapy · 2020
- Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus DevelopmentOncolytic Virotherapy · 2020
- Virus–Receptor Interactions: Structural Insights For Oncolytic Virus DevelopmentOncolytic Virotherapy · 2019
- Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant GliomaOncolytic Virotherapy · 2019
- Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypesOncolytic Virotherapy · 2019
- Development and applications of oncolytic Maraba virus vaccinesOncolytic Virotherapy · 2018
- Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiformeOncolytic Virotherapy · 2018
- Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cellsOncolytic Virotherapy · 2018
- Three-dimensional tumor cell cultures employed in virotherapy researchOncolytic Virotherapy · 2018
- Oncolytic virus and PD-1/PD-L1 blockade combination therapyOncolytic Virotherapy · 2018
- Current understanding of reovirus oncolysis mechanismsOncolytic Virotherapy · 2018
- Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancerOncolytic Virotherapy · 2018
- Oncolytic virotherapy in upper gastrointestinal tract cancersOncolytic Virotherapy · 2018
- The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic virusesOncolytic Virotherapy · 2018
- Potential of oncolytic viruses in the treatment of multiple myelomaOncolytic Virotherapy · 2018
- Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effectOncolytic Virotherapy · 2017
- Proinflammatory response induced by Newcastle disease virus in tumor and normal cellsOncolytic Virotherapy · 2017
- Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunityOncolytic Virotherapy · 2017
- Editorial announcing PubMed indexing of Oncolytic VirotherapyOncolytic Virotherapy · 2017
- Oncolytic virotherapy including Rigvir and standard therapies in malignant melanomaOncolytic Virotherapy · 2017
- Novel oncolytic viral therapies in patients with thoracic malignanciesOncolytic Virotherapy · 2016
- CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapterOncolytic Virotherapy · 2016
- Oncolytic Seneca Valley Virus: past perspectives and future directionsOncolytic Virotherapy · 2016
- Myxoma virus therapy of human embryonal rhabdomyosarcoma in a nude mouse modelOncolytic Virotherapy · 2016
- Oncolytic adenovirus-mediated therapy for prostate cancerOncolytic Virotherapy · 2016
- Thyroid malignancy neoplasm-associated biomarkers as targets for oncolytic virotherapyOncolytic Virotherapy · 2016
- High-throughput screening to enhance oncolytic virus immunotherapyOncolytic Virotherapy · 2016
- Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesOncolytic Virotherapy · 2016
- Combining HDAC inhibitors with oncolytic virotherapy for cancer therapyOncolytic Virotherapy · 2015
- Targeting tumor vasculature through oncolytic virotherapy: recent advancesOncolytic Virotherapy · 2015
- Oncolytic virotherapy using herpes simplex virus: how far have we come?Oncolytic Virotherapy · 2015
- Ultrasound-mediated oncolytic virus delivery and uptake for increased therapeutic efficacy: state of artOncolytic Virotherapy · 2015
- Oncolytic Sendai virus-based virotherapy for cancer: recent advancesOncolytic Virotherapy · 2015
- Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technologyOncolytic Virotherapy · 2015
- Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapyOncolytic Virotherapy · 2015
- Characterization of an oncolytic adenovirus vector constructed to target the cMet receptorOncolytic Virotherapy · 2015
- Oncolytic virotherapy for human malignant mesothelioma: recent advancesOncolytic Virotherapy · 2015
- Advances in the design and development of oncolytic measles virusesOncolytic Virotherapy · 2015
- On the potential of oncolytic virotherapy for the treatment of canine cancersOncolytic Virotherapy · 2015
- Oncolytic virotherapy for head and neck cancer: current research and future developmentsOncolytic Virotherapy · 2015
- Promising oncolytic agents for metastatic breast cancer treatmentOncolytic Virotherapy · 2015
- Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapyOncolytic Virotherapy · 2015
- Therapeutic potential of oncolytic Newcastle disease virus a critical reviewOncolytic Virotherapy · 2015
- Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapyOncolytic Virotherapy · 2015
- The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implicationsOncolytic Virotherapy · 2015
- Extended disease-free interval of 6 years in a recurrent glioblastoma multiforme patient treated with G207 oncolytic viral therapyOncolytic Virotherapy · 2015
- The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)Oncolytic Virotherapy · 2015
- Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor–resistant multiple myelomaOncolytic Virotherapy · 2015
- Immune cells: more than simple carriers for systemic delivery of oncolytic virusesOncolytic Virotherapy · 2014